Aprogen's largest shareholder and related parties file large shareholding report for management influence (including capital reduction adjustment)


  • Report filed for the purpose of affecting management control.
  • Reporting party: Largest shareholder of Aprogen (31.61% stake) and special related parties: GBase, Appten, Jade New Technology Association No. 79.
  • Capital reduction effective April 15, 2026, will adjust the number of shares held.
  • Reporting party financials: Assets 160,058M, Liabilities 64,874M, Equity 95,184M (consolidated, end-2025).
ADVERTISEMENT (250px+)

KOSPI Filing Information


  • Filing: Report on Large Shareholding (General)
  • Company: Aprogen Biologics (003060)
  • Submission: Aprogen, Inc.
  • Receipt: 04-30-2026